All Access Fund
Partners Fund 2023

SingleCell Biotechnology

About SingleCell Biotechnology

Our SCI-AP Platform of High-Density Single-Cell Assays redefines cancer stem cell analysis by integrating unparalleled single-cell data across all three cancer stem cell states. Powered by machine learning (ML), the platform delivers the most accurate and rapid analysis of cancer stem cells available. Utilizing proprietary protocols and custom plates compatible with high-throughput imagers, the system automates data analysis for faster, deeper insights than traditional methods.